Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia

Journal of Medical Virology

Volumn 87, Issue 2, 2015, Pages 199-207

  Darmawan, Erica ^a   Turyadi, ^a   El Khobar, Korri E ^a   Nursanty, Ni Ketut Dias ^a   Thedja, Meta D ^a   Muljono, David Handojo ^a,b,c  

^a EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^b HASANUDDIN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antigenic index; HBsAg mutant; HBV mutation; Hepatitis B virus; Occult hepatitis B

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; HEPATITIS B ANTIBODY;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INDONESIA; MAJOR CLINICAL STUDY; MALE; MUTANT; OCCULT BLOOD TEST; PREVALENCE; SEROEPIDEMIOLOGY; ADOLESCENT; BLOOD; YOUNG ADULT;

HEPATITIS B VIRUS;

ADOLESCENT; ADULT; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; INDONESIA; MALE; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84919952920     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24045     Document Type: Article

References (62)

1. Abdel-Hady M, Kelly D. 2013. Chronic hepatitis B in children and adolescents: Epidemiology and management. Pediatr Drugs 15:311-317.
2. Allain JP. 2004. Occult hepatitis B virus infection: Implications in transfusion. Vox Sang 86:83-91.
3. Avellon A, Echevarría JM, Weber B, Weik M, Schobel U, Willems WR, Gerlich WH. 2011. European collaborative evaluation of Enzygnost HBsAg 6.0: Performance on hepatitis B virus surface antigen variants. J Med Virol 83:95-100.
4. Candotti D, Allain JP. 2009. Transfusion-transmitted hepatitis B virus infection. J Hepatol 51:798-809.
5. Carman WF. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hep 4:S11-S20.
6. Chang MH. 2010. Breakthrough HBV infection in vaccinated children in Taiwan: Surveillance for HBV mutants. Antivir Ther 15:463-469.
7. Chen WN, Oon CJ. 2000. Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti-hepatitis B virus antibody levels but negative for HBsAg. J Clin Microbiol 38:2793-2794.
8. Coleman PF, Chen YC, Mushahwar IK. 1999. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 59:19-24.
9. Creati M, Saleh A, Ruff TA, Stewart T, Otto B, Sutanto A, Clements CJ. 2007. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine 25:5985-5993.
10. Cuestas ML, Mathet VL, Ruiz V, Minassian ML, Rivero C, Sala A, Corach D, Alessio A, Pozzati M, Frider B, Oubina JR. 2006. Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected Argentine patient with anti-HBs antibodies. J Clin Microbiol 44:2191-2198.
11. Ganem D, Prince AM. 2004. Hepatitis B virus infection: Natural history and clinical consequences. N Engl J Med 350:1118-1129.
12. Gerlich W, Glebe D, Schuttler C. 2007. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat 14:16-21.
13. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. 1998. Hepatitis B Virus mutants in liver transplant recipients who were reinfected despite Hepatitis B Immune Globulin prophylaxis. Hepatology 27:213-221.
14. Echevarría JM, Avellón A. 2006. Hepatitis B virus genetic diversity. J Med Virol 78:S36-S42.
15. He C, Nomura F, Itoga S, Isobe K, Nakai T. 2001. Prevalence of vaccine induced escape mutants of hepatitis B virus in the adult population in China: A prospective study in 176 restaurant employees. J Gastroenterol Hepatol 16:1373-1377.
16. Ho MS, Mau YC, Lu CF, Huang SF, Hsu LC, Lin SR, Hsu HM. 1998. Patterns of circulating hepatitis B surface antigen variants among vaccinated children born to hepatitis B surface antigen carrier and non-carrier mothers. J Biomed Science 5:355-362.
17. Hollinger FB. 2007. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 14:S111-S115.
18. Hoofnagle J, Seeff L, Bales Z. 1978. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298:1379-1383.
19. Hou JL, Wang ZH, Cheng JJ, Lin YY, Lau GKK, Sun J, Zhou FY, Karayiannis JWP, Luo KX. 2001. Prevalence of naturally occurring surface gene variants of Hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027-1034.
20. Hsu HY, Chang MH, Ni YH, Chen HL. 2004. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53:1499-1503.
21. Ie SI, Thedja MD, Roni M, Muljono DM. 2010. Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors. Virol J 7:326-334.
22. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. 1992. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 63:107-111.
23. Jameson BA, Wolf H. 1988. The antigenic index: A novel algorithm for prediciting antigenic determinants. Cabios 4:181-186.
24. Jongerius JM, Wester M, Cuypers HTM, van Oostendorp WR, Lelie PN, van der Poel CI, van Leeuwen EF. 1998. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 38:56-58.
25. Kalinina T, Iwanski A, Will H, Sterneck M. 2003. Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274-1281.
26. Katsoulidou A, Paraskevis D, Emmanouil M, Zissis M, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A. 2009. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 81:815-825.
27. Khan M, Dong JJ, Acharya SK, Dhagwahdorj J, Abbas Z, WJafri SM, Mulyono DH, Tozun N, Sarin SK., 2004a. Hepatology issues in Asia: Perspectives from regional leaders. J Gastroenterol Hepatol 19:S419-S443.
28. Khan N, Guarnieri M, Ahn SH, Li J, Zhou Y, Bang G, Kim KH, Wands JR, Tong S. 2004b. Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J Virol 78:3262-3270.
29. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
30. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatol 11:97-107.
31. Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW. 2001. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 16:359-362.
32. Levinick-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain J. 2008. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 48:1022-1025.
33. Lin YM, Jow GM, Mu SC, Chen BF. 2013. Naturally occurring hepatitis B virus B-Cell and T-Cell epitope mutants in hepatitis B vaccinated children. Sci World 571875-571881.
34. Makondo E, Bell TG, Kramvis A. 2012. Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in Southern Africa. PLOS One 7:e46345-46356.
35. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. 2007. Italian blood donors with anti-HBc and occult hepatitis B infection. Haematologica 92:1664-1670.
36. Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T. 2001. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion 41:878-884.
37. Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR. 2001. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 184:905-908.
38. Moerman B, Moons V, Sommer H, Schitt Y, Stetter M. 2004. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 50:159-162.
39. NIHRD. 2010. Report on basic health research in biomedic 2007. Jakarta: National Institute of Health and Research Development, Ministry of Health, Republic of Indonesia. p. 82.
40. Ngui SL, Teo CG. 1997. Hepatitis B virus genomic heterogeneity: Variation between quasispecies may confound molecular epidemiological analyses of transmission incidents. J Viral Hepat 4:309-315.
41. Norder H, Couroce AM, Magnius LO. 1992. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 73:3141-3145.
42. Okamoto H, Nishizawa T. 1992. Non-B non C non-G hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus. http://www.freepatentsonline.com/EP1010759.html (with permission).
43. Quarleri J, Moretti F, Bouzas MD, Laufer N, Carillo MG, Giuliano SF, Perez H, Cahn P, Salomon H. 2007. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses 23:525-531.
44. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trepo C, Villa E, Will H, Zanetti AR, Zoulim F. 2008. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49:652-657.
45. Ren F, Tsubota A, Hirokawa T, Kumada H, Yang Z, Tanaka H. 2006. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Gene 383:43-51.
46. Roznovsky L, Harrison TJ, Fang ZL, Ling R, Lochman I, Orsagova I, Pliskova L. 2000. Unusual hepatitis B surface antigen in antigen variation in a child immunised against hePatitis B. J Med Virol 61:11-14.
47. Ruff TA, Gertig DM, Otto BF, Gust ID, Sutanto A, Soewarso TI, Kandun N, Marschner IA, James E, Maynard JE. 1995. Lombok hepatitis B model immunization project: Toward universal infant hepatitis B immunization in Indonesia. J Infect Dis 171:290-296.
48. Ruiz-Tachiquín ME, Valdez-Salazar HA, Juarez-Barreto V, Dehesa-Violante M, Torres J, Munoz-Hernandez O, Alvarez-Munoz MT. 2007. Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers. Virol J 4:6-13.
49. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karaviannis P. 2000. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60:113-121.
50. Shinkai N, Matsuura K, Sugauchi F, Watanabe T, Murakami S, Iio E, Ogawa S, Nojiri S, Joh T, Tanaka Y. 2013. Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance. J Clin Microbiol 51:3484-3491.
51. Shouval D, Locarnini S. 2012. Increased prevalence of HBV envelope mutants in Taiwan: An merging public risk or false alarm? Gastroenterol 143:290-293.
52. Thedja M, Martono R, Harahap AR, Sireger NC, Ie SI, Muljono DH. 2010. Occult hepatitis B in blood donors in Indonesia: Altered antigenicity of hepatitis B virus surface protein. Hepatol Int 4:608-614.
53. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, Lu M, Yang D. 2007. The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45:2971-2978.
54. Torbenson M, Thomas D. 2002. Occult hepatitis B. Lancet Infect Dis 2:479-486.
55. Torresi J. 2002. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 25:97-106.
56. Turyadi, Thedja MD, Ie SI, Harahap El AR, Khobar KE, Roni M, Muljono DH. 2013. HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B patients in Indonesia. Hepatol Int 7:969-980.
57. Utsumi T, Yano Y, Lusida MI, Amin M, Soetjipto, Hotta H, Hayashi Y. 2010. Serologic and molecular characteristics of Hepatitis B virus among school children in East Java, Indonesia. Am J Trop Med Hyg 83:189-193.
58. Vivekanandan P, Kannangai R, Ray SC, Thomas DL, Torbenson M. 2008. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis 46:1227-1236.
59. Weber B. 2006. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78:S59-S65.
60. World Health Organization. 2009a. Review of National Immunization Coverage 1980-2008. Retrieved July 2013, from http://www.who.int/immunization_monitoring/data/idn.pdf.
61. World Health Organization. 2009b. Hepatitis B vaccines-WHO position paper. Wkly Epidemiol Rec 84:405-420.
62. World Health Organization. 2013. Hepatitis B: Fact Sheet no.204. Retrieved July 2013 from http://www.who.int/mediacentre/factsheets/fs204/en/.